Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Walker

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma PatientsS Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
Blood|May 24, 2013
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myelomaMartin F Kaiser, David C Johnson, Ping Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatmentPing Wu, Brian A Walker, Daniel Brewer, et al.
Blood Advances|January 29, 2020
Long-term outcomes after autologous stem cell transplantation for multiple myelomaKatherine K Nishimura, Bart Barlogie, Frits van Rhee, et al.
Oncotarget|May 28, 2015
The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathwayEmma M Smith, Lei Zhang, Brian A Walker, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancerHussein Ghamlouch, Eileen M Boyle, Patrick Blaney, et al.
Frontiers in Genetics|May 10, 2021
Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma PatientsDuojiao Chen, Mohammad I Abu Zaid, Jill L Reiter, et al.
Blood|February 26, 2013
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cellsBrian A Walker, Christopher P Wardell, David C Johnson, et al.
Genome Medicine|July 15, 2025
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroupsEnze Liu, Oumaima Jaouadi, Riya Sharma, et al.
Blood|April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatmentsTina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma PatientsS Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
Blood|May 24, 2013
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myelomaMartin F Kaiser, David C Johnson, Ping Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatmentPing Wu, Brian A Walker, Daniel Brewer, et al.
Blood Advances|January 29, 2020
Long-term outcomes after autologous stem cell transplantation for multiple myelomaKatherine K Nishimura, Bart Barlogie, Frits van Rhee, et al.
Oncotarget|May 28, 2015
The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathwayEmma M Smith, Lei Zhang, Brian A Walker, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancerHussein Ghamlouch, Eileen M Boyle, Patrick Blaney, et al.
Frontiers in Genetics|May 10, 2021
Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma PatientsDuojiao Chen, Mohammad I Abu Zaid, Jill L Reiter, et al.
Blood|February 26, 2013
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cellsBrian A Walker, Christopher P Wardell, David C Johnson, et al.
Genome Medicine|July 15, 2025
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroupsEnze Liu, Oumaima Jaouadi, Riya Sharma, et al.
Blood|April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatmentsTina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Pageof 14